Epithelial cell lines such as Vero and MDCK are used in the production of viral based vaccines. The use of cell based vaccines is growing. The majority of the vaccines in use today are produced in medium supplemented with serum. The use of animal-derived products in vaccine culture media presents a risk for the transmission of infectious disease on a wide scale. Current commercially available serum-free vaccine media, are not defined, inconsistent, and do not offer the same performance as media supplemented with serum. We propose to produce a superior performance, defined, animal-free, cell culture medium for vaccine production. Our project addresses the call by agencies for a safe alternative to animal-derived components in vaccine production.

Public Health Relevance

Epithelial cell lines such as Vero and MDCK are used in the generation of viral based vaccines and their use is expanding. Current commercially available animal-free vaccine production media are not defined and do not offer the same performance as media supplemented with serum. We propose the industry's first defined, high performance animal-free, cell culture medium to increase safety and the production of vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI092916-01A1
Application #
8201046
Study Section
Special Emphasis Panel (ZRG1-IMM-N (12))
Program Officer
Prograis, Lawrence J
Project Start
2011-07-08
Project End
2012-02-29
Budget Start
2011-07-08
Budget End
2012-02-29
Support Year
1
Fiscal Year
2011
Total Cost
$158,820
Indirect Cost
Name
Ventria Bioscience
Department
Type
DUNS #
932816929
City
Fort Collins
State
CO
Country
United States
Zip Code
80524